Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
64
ALNY Quote, Financials, Valuation and Earnings
Last price:
$321.37
Seasonality move
:
7.34%
Day range:
$311.26 - $323.41
52-week range:
$205.87 - $333.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
17.67x
P/B ratio:
364.63x
Volume:
1.2M
Avg. volume:
859.5K
1-year change:
29.21%
Market cap:
$42.1B
Revenue:
$2.2B
EPS (TTM):
-$2.09
Earnings Data
Next earnings date for ALNY
Aug 01
2025
Most recent earnings per share
-$0.44
Missed by $0.07
(May 1/2025)
Consensus Estimate
-$0.37
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ALNY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $727.7M | -- | -- | $0.43 | -- |
| 08/01/2025 | Q2 | $646.1M | -- | -- | $0.07 | -- |
| 05/01/2025 | Q1 | $581.2M | $594.2M | -$0.44 | -$0.37 | -$0.07 |
| 02/13/2025 | Q4 | $580.6M | $593.2M | -$0.65 | -$0.14 | -$0.51 |
| 10/31/2024 | Q3 | $527M | $500.9M | -$0.87 | -$0.39 | -$0.48 |
| 08/01/2024 | Q2 | $444.2M | $659.8M | -$0.13 | -$0.69 | $0.56 |
| 05/02/2024 | Q1 | $426.7M | $494.3M | -$0.52 | -$0.63 | $0.11 |
| 02/15/2024 | Q4 | $442.3M | $439.7M | -$1.10 | -$0.77 | -$0.33 |
| 11/02/2023 | Q3 | -- | -- | $1.15 | -$0.96 | $2.11 |
| 08/03/2023 | Q2 | -- | -- | -$2.21 | -$1.34 | -$0.87 |
| 05/04/2023 | Q1 | -- | -- | -$1.40 | -$1.43 | $0.03 |
| 02/23/2023 | Q4 | -- | -- | -$1.68 | -$1.48 | -$0.20 |
| 10/27/2022 | Q3 | -- | -- | -$3.32 | -$1.38 | -$1.94 |
| 07/28/2022 | Q2 | -- | -- | -$2.29 | -$1.36 | -$0.93 |
| 04/28/2022 | Q1 | -- | -- | -$2.00 | -$1.46 | -$0.54 |
| 02/10/2022 | Q4 | -- | -- | -$2.16 | -$1.26 | -$0.90 |
| 10/28/2021 | Q3 | -- | -- | -$1.72 | -$1.24 | -$0.48 |
| 08/03/2021 | Q2 | -- | -- | -$1.61 | -$1.28 | -$0.33 |
| 04/29/2021 | Q1 | -- | -- | -$1.71 | -$1.40 | -$0.31 |
| 02/11/2021 | Q4 | -- | -- | -$2.09 | -$1.38 | -$0.71 |
| 11/05/2020 | Q3 | -- | -- | -$2.18 | -$1.34 | -$0.84 |
| 08/06/2020 | Q2 | -- | -- | -$1.56 | -$1.40 | -$0.16 |
| 05/06/2020 | Q1 | -- | -- | -$1.62 | -$1.51 | -$0.11 |
| 02/06/2020 | Q4 | -- | -- | -$2.47 | -$1.92 | -$0.55 |
| 10/31/2019 | Q3 | -- | -- | -$1.92 | -$1.83 | -$0.09 |
| 08/06/2019 | Q2 | -- | -- | -$1.83 | -$1.85 | $0.02 |
| 05/01/2019 | Q1 | -- | -- | -$1.42 | -$1.80 | $0.38 |
| 02/07/2019 | Q4 | -- | -- | -$1.82 | -$1.93 | $0.11 |
| 11/07/2018 | Q3 | -- | -- | -$1.56 | -$1.79 | $0.23 |
| 08/02/2018 | Q2 | -- | -- | -$1.83 | -$1.71 | -$0.12 |
| 05/03/2018 | Q1 | -- | -- | -$1.41 | -$1.51 | $0.10 |
| 02/08/2018 | Q4 | -- | -- | -$1.48 | -$1.36 | -$0.12 |
| 11/07/2017 | Q3 | -- | -- | -$1.34 | -$1.23 | -$0.11 |
| 08/09/2017 | Q2 | -- | -- | -$1.34 | -$1.17 | -$0.17 |
| 05/05/2017 | Q1 | -- | -- | -$1.25 | -$1.24 | -$0.01 |
| 02/08/2017 | Q4 | -- | -- | -$1.32 | -$1.31 | -$0.01 |
| 11/02/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/02/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/11/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
Alnylam Pharmaceuticals Earnings Questions
-
How Much did Alnylam Pharmaceuticals Generate in Revenue Last Quarter?
Alnylam Pharmaceuticals reported $594.2M worth of top line sales in its most recent quarter.
-
Did Alnylam Pharmaceuticals Beat Earnings Last Quarter?
Alnylam Pharmaceuticals announced earnings per share of -$0.44 which represents a miss of analyst forecast a -$0.37 per share.
-
Is Alnylam Pharmaceuticals Profitable?
Alnylam Pharmaceuticals reported $523.1M that represents $4.03 per share over the last quarter.
-
What is the Analyst Consensus for Alnylam Pharmaceuticals EPS Next Year?
Alnylam Pharmaceuticals's earnings are forecast to decrease from -$2.18 per share to -$0.24 per share next year representing a decrease of -93.04%.
-
When is Alnylam Pharmaceuticals's Earnings Date?
Alnylam Pharmaceuticals's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 0.83% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 5.71% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.54% over the past day.
